These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. Jordan VC; Gapstur S; Morrow M J Natl Cancer Inst; 2001 Oct; 93(19):1449-57. PubMed ID: 11584060 [TBL] [Abstract][Full Text] [Related]
8. Review of raloxifene and its clinical applications in osteoporosis. Maricic M; Gluck O Expert Opin Pharmacother; 2002 Jun; 3(6):767-75. PubMed ID: 12036416 [TBL] [Abstract][Full Text] [Related]
9. Benefit-risk assessment of raloxifene in postmenopausal osteoporosis. Cranney A; Adachi JD Drug Saf; 2005; 28(8):721-30. PubMed ID: 16048357 [TBL] [Abstract][Full Text] [Related]
10. The search for the ideal SERM. Arun B; Anthony M; Dunn B Expert Opin Pharmacother; 2002 Jun; 3(6):681-91. PubMed ID: 12036407 [TBL] [Abstract][Full Text] [Related]
11. ACOG practice bulletin. Selective estrogen receptor modulators. Number 39, October 2002 (replaces Committee Opinion Number 224, October 1999). American College of Obsterticians and Gynecologists Committee on Practice Bulletins-Gynecology Int J Gynaecol Obstet; 2002 Dec; 79(3):289-98. PubMed ID: 12501867 [TBL] [Abstract][Full Text] [Related]
12. Raloxifene for older women: a review of the literature. Hansdóttir H Clin Interv Aging; 2008; 3(1):45-50. PubMed ID: 18488877 [TBL] [Abstract][Full Text] [Related]
13. Raloxifene: A selective estrogen receptor modulator (SERM) with multiple target system effects. Muchmore DB Oncologist; 2000; 5(5):388-92. PubMed ID: 11040275 [TBL] [Abstract][Full Text] [Related]
14. Selective estrogen receptors modulators in the prevention and treatment of postmenopausal osteoporosis. Fontana A; Delmas PD Endocrinol Metab Clin North Am; 2003 Mar; 32(1):219-32. PubMed ID: 12699300 [TBL] [Abstract][Full Text] [Related]
15. Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats. Gogos A; van den Buuse M Schizophr Res; 2015 Nov; 168(3):634-9. PubMed ID: 25979306 [TBL] [Abstract][Full Text] [Related]
17. Water extract of Er-xian decoction selectively exerts estrogenic activities and interacts with SERMs in estrogen-sensitive tissues. Wong KY; Zhou L; Yu W; Poon CC; Xiao H; Chan CO; Mok DK; Wong MS J Ethnopharmacol; 2021 Jul; 275():114096. PubMed ID: 33823166 [TBL] [Abstract][Full Text] [Related]
18. The benefits of estrogen or selective estrogen receptor modulator on kidney and its related disease-chronic kidney disease-mineral and bone disorder: osteoporosis. Lee WL; Cheng MH; Tarng DC; Yang WC; Lee FK; Wang PH J Chin Med Assoc; 2013 Jul; 76(7):365-71. PubMed ID: 23664736 [TBL] [Abstract][Full Text] [Related]
19. Oestrogens for treatment or prevention of pelvic organ prolapse in postmenopausal women. Ismail SI; Bain C; Hagen S Cochrane Database Syst Rev; 2010 Sep; (9):CD007063. PubMed ID: 20824855 [TBL] [Abstract][Full Text] [Related]
20. Tamoxifen to raloxifene and beyond. O'Regan RM; Jordan VC Semin Oncol; 2001 Jun; 28(3):260-73. PubMed ID: 11402436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]